naabt masthead for buprenorphine site

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®3, Zubsolv®4, Bunavail™5, Probuphine®6) is an opioid medication used to treat opioid addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed for take-home use, by prescription.1 This, in addition to the pharmacological and safety profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Attention: Marketing Survey - Starting 9/09/2014

Survey ended 9/12/2014 7:27pm ET - thank you.
COMPLETED

If you are currently taking a buprenorphine-based product for the treatment of opioid addiction and you live in the US, please consider taking this survey sponsored by a buprenorphine product manufacturer*. The purpose of this survey is to evaluate:

This survey consists of mostly short answer questions, with some multiple choice and yes/no questions. The survey will take about 15-20 minutes to thoughtfully complete. This survey can only be taken online.

Your responses to survey questions will be encrypted, anonymous and confidential. Read survey privacy policy here

To thank you for taking the time to think about each question and provide a thoughtful answer, a one-time $100 AMEX gift card will be offered to all who submit a usable response set (i.e., without blank fields, erroneous, incomplete, or incoherent answers). The card can be used wherever American Express is accepted. Instructions for obtaining the gift card will be provided when the survey has been completed. If you choose, you can have the gift card sent to someone else by filling in their name and address.

Your answers may help shape the future of buprenorphine treatment and the options available to patients. The insight you provide may help correct assumptions industry leaders have made, and as a result, you can contribute to a more effective treatment. So even if you don't need the $100 honorarium, please consider taking this survey to make your voice heard.

Payment can be expected within 10 days of completing the survey. All cards will be sent Priority Mail via the USPS.

If you have technical problems, or other questions please contact Tim at: CONTACT.

Survey ENDED 9/12/2014
All payments have been sent

If your redemption code started with "BRK-2___" please contact us (with the rest of the code). Your gift card was returned to sender. All other cards have been delivered and signed for.

*NAABT has thoroughly vetted this opportunity and can confirm it is a respectable organization.

This page was last modified on : 10/14/2014

The Purpose of Buprenorphine Treatment:

To suppress the debilitating symptoms of cravings and withdrawal, enabling the patient to engage in therapy, counseling and support, so they can implement positive long-term changes in their lives which develops into the new healthy patterns of behavior necessary to achieve sustained addiction remission. - explain -

The National Alliance of Advocates for Buprenorphine Treatment is a non-profit organization charged with the mission to:

  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.
  3. Subutex Discontinued in the US market in late 2011.
  4. Zubsolv (bup/nx sublingual tablet) FDA approved 7/3/2013 see buprenorphine pipeline graphic -in pharmacies now.
  5. Bunavail (bup/nx bucal film) FDA approved 6/6/2014 see buprenorphine pipeline graphic -in pharmacies now.
  6. Probuphine FDA approved 5/26/2016 - FDA Probuphine press release